AN2 Therapeutics, Inc. Profile Avatar - Palmy Investing

AN2 Therapeutics, Inc.

AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous …

Biotechnology
US, Menlo Park [HQ]

Resulting Ratios

5 Records · Starting from 2019
Loading...
End of ANTX's Analysis
CIK: 1880438 CUSIP: 037326105 ISIN: US0373261058 LEI: - UEI: -
Secondary Listings
ANTX has no secondary listings inside our databases.